Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US
Mylan is offering Semglee at a wholesale acquisition cost (WAC) of $147.98 per package of five 3ml pens and $98.65 per 10ml vial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
insulin glargine injection
Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection
FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans…